FB23-2
- CAS No.
- 2243736-45-8
- Chemical Name:
- FB23-2
- Synonyms
- FB23-2;FB23-2,1.5g;FB23-2, 10 mM in DMSO;FB23-2(FTO Demethylase inhibitor FB23-2);2-[[2,6-Dichloro-4-(3,5-dimethyl-4-isoxazolyl)phenyl]amino]-N-hydroxybenzamide;2-((2,6-Dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)-N-hydroxybenzamide;Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-4-isoxazolyl)phenyl]amino]-N-hydroxy-;FB23 2,AML,Apoptosis,leukemia,acute,anti-proliferation,Inhibitor,FB232,m6A,myeloid,mRNA,inhibit,FB23-2,demethylase,FB-23-2
- CBNumber:
- CB84908508
- Molecular Formula:
- C18H15Cl2N3O3
- Molecular Weight:
- 392.24
- MDL Number:
- MFCD32174281
- MOL File:
- 2243736-45-8.mol
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H315-H319-H335 |
Precautionary statements | P233-P260-P261-P264-P271-P280-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501 |
FB23-2 price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Biorbyt Ltd | orb611563 | FB23-2 (FTO Demethylase inhibitor FB23-2) | 2243736-45-8 | 100mg | $1654.1 | 2021-12-16 | Buy |
Biorbyt Ltd | orb611563 | FB23-2 (FTO Demethylase inhibitor FB23-2) | 2243736-45-8 | 250mg | $3282.7 | 2021-12-16 | Buy |
Biorbyt Ltd | orb611563 | FB23-2 (FTO Demethylase inhibitor FB23-2) | 2243736-45-8 | 1g | $6545 | 2021-12-16 | Buy |
DC Chemicals | DC23119 | FB23-2(FTODemethylaseinhibitorFB23-2) >98% | 2243736-45-8 | 1g | $2800 | 2021-12-16 | Buy |
DC Chemicals | DC23119 | FB23-2(FTODemethylaseinhibitorFB23-2) >98% | 2243736-45-8 | 100mg | $800 | 2021-12-16 | Buy |
FB23-2 Chemical Properties,Uses,Production
Uses
FB23-2 is a potent and selective inhibitor of mRNA N6-methyladenosine (m6A) demethylase FTO, with an IC50 of 2.6 μM. FB23-2 has anti-proliferation activity. FB23-2 can be used for the research of acute myeloid leukemia (AML)[1].
in vivo
FB23-2 (2 mg/kg; i.p.; daily; for 10 days) substantially suppresses leukemia progression and prolongs survival[1].
FB23-2 exhibits elimination half-life (rat 6.7 h) and Cmax (rat 2421.3 ng/mL) following intraperitoneal injection (rat 3 mg/kg)[1].
Animal Model: | NOD/LtSz-scid IL2RG-SGM3 (NSGS) mice, xeno-transplanted with MONOMAC6 AML cells[1] |
Dosage: | 2 mg/kg |
Administration: | Intraperitoneal injection, daily, for 10 days |
Result: | Delayed the onset of full-blown leukemic symptoms and significantly prolonged survival by almost doubling the median survival. |
Animal Model: | Sprague Dawley (SD) rats[1] |
Dosage: | 3 mg/kg (Pharmacokinetic Analysis) |
Administration: | Intraperitoneal injection |
Result: | T1/2 (6.7 hours), Cmax (2421.3 ng/mL). |
References
[1] Huang Y, et al. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell. 2019 Apr 15;35(4):677-691.e10. DOI:10.1016/j.ccell.2019.03.006
FB23-2 Preparation Products And Raw materials
Raw materials
Preparation Products
FB23-2 Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32268 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10473 | 58 |
CR Corporation Limited | +8613062833949 | fred.wen@crcorporation.cn | China | 8647 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
LEAP CHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 24727 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3135 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38664 | 58 | |
Chemtour Biotech Co., Ltd | +8617327281506 | market@chemtour.com | China | 1521 | 58 |
Aladdin Scientific | tp@aladdinsci.com | United States | 57505 | 58 |